Erica Bell Discusses Prognostic Factors for Grade 2 Gliomas
Erica Bell, PhD, assistant professor of Radiation Oncology at The Ohio State University, discusses prognostic factors for patients diagnosed with grade 2 gliomas.
Erica Bell, PhD, assistant professor of Radiation Oncology at The Ohio State University, discusses prognostic factors for patients diagnosed with grade 2 gliomas.
Bell explains that there are many subsets of patients in this setting, as gliomas have been recently reclassified to incorporate molecular parameters that are extremely important in understanding prognosis and treatment selection. For example, some grade 2 gliomas are classified as IDH wild-type and resemble glioblastoma. Thus, when patients are diagnosed with grade 2 glioma, their treatment plan and outcome can be vastly different than other patients with the same malignancy.
Oncology Nurses Provide Patients an Avenue to Supportive Care
November 12th 2019Palliative care is often associated with a patient entering end of life treatment and giving up on their treatment, but that isn't the reality of what id can do for patients. And oncology nurses can help guide patients to the right supportive care for them.
Hyman B. Muss Discusses the Importance of Nurses in Treating Pregnant Women With Breast Cancer
March 23rd 2016Hyman B. Muss, MD, professor of medicine at the University of North Carolina School of Medicine, discusses the vital roles that nurses play when it comes to treating pregnant women with breast cancer.
Kimberly J. Van Zee on Nomograms Helping in DCIS Treatment Decision-Making
March 18th 2016Kimberly J. Van Zee, MS, MD, FACS, attending surgeon at Memorial Sloan Kettering Cancer Center, discusses the institution's newly-developed nomogram that can help women make treatment decisions about ductal carcinoma in situ (DCIS).
